Waystar Q1 Results Confirm Strong Demand, But Valuation Keeps Us on Sidelines

What happened

Waystar reported Q1 revenue growth of 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, indicating robust demand and customer expansion. The company's revised guidance has been interpreted by management as a timing issue from a faster shift to digital patient payments, not a structural slowdown. However, the DeepValue Master Report maintains a WAIT stance, citing a trailing P/E of ~58x and EV/EBITDA of 13.5x, with the stock trading 66% above DCF intrinsic value. While the business quality is attractive with recurring revenue and improving free cash flow, the leverage (3.5x net debt/EBITDA) and high multiples leave limited margin of safety. Overall, the Q1 results confirm the growth narrative, but the risk-reward remains unfavorable until valuation corrects or deleveraging progresses.

Implication

Investors should remain cautious as the stock's premium valuation and leverage require flawless execution; a pullback to DCF-implied levels (~$22) or evidence of sustained growth with deleveraging would improve the risk-reward.

Thesis delta

The Q1 numbers show strong growth and retention, partly alleviating demand fears, but they do not change the fundamental valuation and leverage concerns. The thesis shifts slightly from 'wait for better entry' to 'wait for better entry or clearer signs of margin expansion,' as the underlying business is performing well. No upgrade is warranted until valuation becomes more reasonable.